
Sourced report
Source11 months ago
OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial
The Phase 2 trial is not definitive, but it comes as vaccine access is severely restricted. ...
2 min briefingRead signal →
2 premium articles in this collection

The Phase 2 trial is not definitive, but it comes as vaccine access is severely restricted. ...

If drug developers are allowed to skip this step, it will mean that, in the near future, the first living body a new drug is ever tested in will be a human....